Primary aldosteronism (PA) is a common form of endocrine hypertension that is characterized by the excessive production of aldosterone relative to suppressed plasma renin levels. PA is usually caused by either a unilateral aldosterone-producing adenoma or bilateral adrenal hyperplasia. Somatic mutations have been identified in several genes that encode ion pumps and channels that may explain the aldosterone excess in over half of aldosterone-producing adenomas, whereas the pathophysiology of bilateral adrenal hyperplasia is largely unknown. A number of mouse models of hyperaldosteronism have been described that recreate some features of the human disorder, although none replicate the genetic basis of human PA. Animal models that reproduce the genotype-phenotype associations of human PA are required to establish the functional mechanisms that underlie the endocrine autonomy and deregulated cell growth of the affected adrenal and for preclinical studies of novel therapeutics. Herein, we discuss the differences in adrenal physiology across species and describe the genetically modified mouse models of PA that have been developed to date. (Endocrinology 158: 4129-4138, 2017) 
P rimary aldosteronism (PA) is the most common form of endocrine hypertension, characterized by the excessive production of aldosterone relative to suppressed plasma renin, and is associated with an increased risk of cardiovascular and cerebrovascular complications (1, 2) . PA is predominantly caused by either of two main subtypes: unilateral aldosterone excess, due to an aldosterone-producing adenoma, or bilateral aldosterone excess, caused by bilateral adrenal hyperplasia. Unilateral PA is treated by adrenalectomy, whereas patients with bilateral PA are usually treated pharmacologically with a mineralocorticoid receptor antagonist (3) .
Major advances have been made in our understanding of the pathogenesis of aldosterone-producing adenomas with the discovery of somatic mutations in a number of genes that can explain the overproduction of aldosterone in over half of patients with a unilateral aldosteroneproducing adenoma. The affected genes encode ion pumps and channels (KCNJ5, ATP1A1, ATP2B3, and CACNA1D) or key players in the control of cell growth (CTNNB1 and PRKACA) (4) . Mutations in several of the affected genes (KCNJ5, ATP2B3, and CACNA1D) have been shown to cause an increase in intracellular Ca 2+ concentration that results in an increase in transcription of the gene encoding aldosterone synthase (CYP11B2) via the activation of Ca 2+ signaling (5) (6) (7) . In contrast, mutations in ATP1A1 (Na + /K + -ATPase 1-Leu104Arg and Val332Gly) result in intracellular acidification that may cause the overproduction of aldosterone (8) . The pathogenesis of bilateral adrenal hyperplasia, however, remains obscure, mainly because molecular studies are hampered as a result of the limited availability of resected adrenal specimens from patients with bilateral adrenal hyperplasia who are treated pharmacologically. Animal models of PA would be useful to study mechanisms that control cell growth and autonomous aldosterone production and for preclinical testing of novel therapeutics. In this review, we discuss adrenal physiology in different animal species and describe the currently available mouse models of hyperaldosteronism.
Physiology of the Adrenal Gland in Different Species
The human adrenal cortex comprises three morphologically distinct zones: the zona glomerulosa (zG), zona fasciculata (zF), and zona reticularis (zR), which have specific functional properties for the production of mineralocorticoids, glucocorticoids, and androgens, respectively (referred to as "functional zonation"). In the normal human adrenal gland, the restricted synthesis of aldosterone in the zG and of cortisol in the zF is a result of the adrenal expression of CYP11B2 exclusively in the zG for aldosterone synthesis and the expression of CYP17 and the gene encoding 11b-hydroxylase (CYP11B1) in the zF for cortisol production (9, 10) (Fig. 1) .
The adrenal cortices of pigs, dogs, and cattle are similarly functionally organized to those of humans with aldosterone biosynthesis restricted to cells of the zG and cortisol production in the zF. Mice display a different morphological zonation compared with humans. The CYP17 gene encoding 17a-hydroxylase and 17,20-lyase is not expressed in mice, as in other rodents, and therefore, mice produce corticosterone instead of cortisol and do not synthesize adrenal androgens. A functional zR is thus absent in mice, and this zone is difficult to distinguish histologically ( Fig. 1 ; Table 1 ).
The adrenals of young mice have a layer of juxtamedullary cortical cells (the X-zone) with an undefined function (11) . The X-zone degenerates during the first pregnancy of female mice, disappearing by the 12th day of gestation, and by puberty in male mice. In the absence of pregnancy, the X-zone nonetheless degenerates in females but slowly over a variable period that may last up to 200 days (11) . The adrenals of female mice have a notably higher weight and total volume of the cortex and medulla than those of males from the age of five weeks that is maintained into adulthood (12) .
In humans, the final three steps in the biosynthesis of aldosterone involve the conversion of deoxycorticosterone by the successive action of the 11b-hydroxylase, 18-hydroxylase, and 18-methyloxidase activities of a single enzyme, aldosterone synthase, encoded by CYP11B2 (9, 10). An 11b-hydroxylase in the zF, encoded by a distinct but highly homologous gene to CYP11B2, called CYP11B1, converts 11-deoxycortisol to cortisol. Humans, mice, rats, hamsters, guinea pigs, and monkeys express two CYP11B enzymes, whereas cows, sheep, horses, pigs, and dogs express a single CYP11B enzyme that catalyzes the final step(s) in the synthesis of both cortisol and aldosterone (13) (14) (15) (16) (17) (18) (Table 1) . Despite the presence of a single CYP11B in these species, functional zonation with aldosterone production in the zG and cortisol synthesis in the zF is maintained by an unknown mechanism, which presumably involves the presence of zone-specific factors that modulate CYP11B activity.
Regulation of Aldosterone Synthesis in Humans and Other Species
The principal function of aldosterone is to maintain fluid and electrolyte balance, promoting Na + retention and K + secretion in the distal nephron of the kidney, thereby controlling blood pressure (10) . In zG cells, angiotensin II (Ang II) stimulates phospholipase C and triggers inositol triphosphate-dependent Ca 2+ release from the endoplasmic reticulum, whereas high plasma K + concentrations or long-term stimulation by Ang II result in membrane depolarization and the activation of L-and Ttype Ca 2+ channels (19) . The increase in intracellular Ca
2+
leads to an increase in expression of the gene encoding aldosterone synthase (CYP11B2) and aldosterone production (17) . Small changes in plasma K + , as low as 1 mM, can double aldosterone secretion (20) . The basis of this sensitivity is the high background K + conductance with a membrane potential close to the K + equilibrium potential. At low plasma K + concentrations, the membrane voltage is hyperpolarized, and small increases in K + are sufficient to depolarize slightly the membrane and activate T-type Ca 2+ channels (21) (22) (23) . Therefore, mechanisms that regulate the membrane potential of the zG cell play a crucial role in the control of aldosterone production and usually depend on the equilibrium potential and ion conductance across the plasma membrane. The negative membrane voltage is mainly determined by two-pore domain K + channels, the tandem of P domains in weak, inwardly rectifying, K + channelrelated, acid-sensitive K + channels (TASK channels), which generate the aforementioned background or "leak" K + currents. K + inwardly rectifying channels [G protein-activated inwardly rectifying K + channels (GIRK)] also regulate the membrane potential of zG cells, and GIRK4 (encoded by KCNJ5) may function in normal adrenal physiology, in addition to its pathological role in aldosterone production via gain-of-function mutations, as described previously.
Different species use different K + channels to maintain the membrane potential of the zG cell (24) and distinct differences between species have been reported for the expression of some key K + channels (25) . TASK-1 is expressed in the zG and zF in both humans and rats. TASK3 is localized to the zG in the human and rat adrenal with high expression in the rat and low expression in the human (25) . GIRK4 (KCNJ5) is strongly expressed in the Figure 1 . Cholesterol is mobilized from a store in the outer mitochondrial membrane (OMM) and is transferred by steroidogenic acute regulatory protein (StAR) to the inner mitochondrial membrane (IMM), where it is converted to pregnenolone by P450scc, the first and rate-limiting step of steroidogenesis (9, 10) . Aldosterone biosynthesis is restricted to the zG, where aldosterone synthase is localized. (A) In humans, the activity of 17a-hydroxylase (17aOHase)/17,20 lyase (CYP17A1) is a key enzyme for the synthesis of both cortisol and androgens; the main biosynthetic pathway for cortisol synthesis is via the 17a-hydroxylation of pregnenolone, indicated by thicker arrows. (B) Mice, like other rodents, do not express CYP17A1 and, as a result, the major glucocorticoid synthesized is corticosterone (instead of cortisol), which is produced from deoxycorticosterone by 11b-hydroxylase [11bOHase (Cyp11b1)] in the zF. (A and B) The absence of CYP17A1 expression in mice means that adrenal androgens cannot be synthesized as in humans in the zR, and mice do not have a distinguishable zR. (B) Young mice have an X-zone that degenerates by the first pregnancy in females and by sexual maturity in males. Figure 1 includes data from Stowasser and Gordon (10) . 21OHase, 21-hydroxylase; 3bHSD, 3b-hydroxysteroid dehydrogenase; Aldo synthase, aldosterone synthase; DHEAS, dehydroepiandrosterone sulfate; STS, steroid sulfatase.
zG of the human adrenal but is undetectable in the rat zG and zF (25) . Thus, the distinct expression patterns of K + channels between species suggests an evolutionary divergence in the regulation of aldosterone production and indicates that rats and probably also mice may not be ideal models to study human pathological conditions of aldosterone excess.
Mouse Models of Primary Aldosteronism
Several genetically modified mouse models of hyperaldosteronism have been reported that display the main biochemical features of PA but do not reproduce the adrenal tumorigenesis or hyperplasia associated with this condition. Mouse models of hyperaldosteronism are discussed further later and are summarized in Table 2 .
Mouse Models With Deletions of TASK Channels
Electrophysiological recordings of zG cells have emphasized the importance of leak-type K + channels of the two-pore domain family in conferring background K + conductance. In rodents, two members of the two-pore domain family, Task1 (Kcnk3) and Task3 (Kcnk9), are the dominant leak-type channels. Female mice with the Task1 gene deleted display hyperaldosteronism with low plasma renin activity and a decrease in plasma K + . Systolic blood pressure is increased and responds to administration of a mineralocorticoid receptor antagonist (26) . The Cyp11b2 gene is expressed aberrantly exclusively in the zF, and the elevated aldosterone is suppressed by dexamethasone (26) . Male Task1 2/2 mice and heterozygous females do not exhibit a phenotype. Mice of both sexes at postnatal day 18 exhibit an abnormal distribution of the Cyp11b2 enzyme. Castrated male Task1 2/2 display an abnormal expression of Cyp11b2, similar to females, and estradiol administration decreases the level of Cyp11b2 expression but not the zonal distribution. Female Task1 2/2 injected with testosterone display a normal zonation indicating the role of androgens (26) .
Gene expression analysis of the adrenals of male and female Task1 2/2 revealed a limited number of differentially expressed genes, mostly involved in signaling cascades, and one of these belongs to the dickkopf family (Dkk3) which is expressed in the zG of the adrenal and inhibits aldosterone secretion in cultured adrenal cells (27 was preserved in contrast to female Task1 2/2 mice.
TASK1 (KCNK3) is expressed in both mouse and human adrenals. In the human adrenocortical NCI-H295R cell line, downregulation of TASK1 by a small interfering RNA increased aldosterone production (40). Genome-wide association studies have identified KCNK3 single nucleotide polymorphism (SNP) variants associated with blood pressure in humans (41) . The KCNK3 SNP (rs1275988) is associated with hypertension in African Americans and a nearby SNP (rs13394970) is associated with hypertension in Hispanics, which was found in the Multi-Ethnic Study of Atherosclerosis, which comprised 7840 individuals. Aldosterone levels and plasma renin activity, in a subset of 1653 participants, were also found associated with KCNK3 rs2586886 (41) . The functional significance of these SNPs on channel function is unknown, and whereas in the mouse, complete deletion of Kcnk3 in females is required for the phenotype, an alteration determined by a polymorphism is of unknown significance in humans.
Gene deletion of both the Task1 and Task3 in male mice ablates background K + currents, resulting in marked depolarization of the membrane potential in zG cells (28) . Task1 2/2 , Task3 2/2 mice excrete higher urinary aldosterone at all levels of sodium intake. The mice also have normal or low renin activity, and aldosterone production fails to normalize on high sodium intake or after the administration of the Ang receptor blocker candesartan (28) . Adrenal zonation is unaltered, and Task1 2/2 , Task3 2/2 mice may represent a model of idiopathic PA.
Task3
2/2 mice display mild aldosterone overproduction and a decreased plasma renin concentration and fail to suppress aldosterone excretion on a high sodium diet. These mice are hypersensitive to Ang II and have high blood pressure (29, 30) . The baseline membrane potential of zG cells was not different from that of wildtype mice, even though the mice were slightly hypokalemic. Although there was a small increase in Cyp11b2 mRNA, there was no increase in aldosterone synthase expression. A recent study indicates that TASK3 is not located in the plasma membrane but is located in the mitochondrial membrane and plays a role in mitochondrial membrane potential (42) . It has been suggested that the lack of plasma membrane depolarization, unchanged expression of the Cyp11b2
protein, but increased production of aldosterone might result from an increase in the activity of the late pathway of aldosterone biosynthesis (43) (conversion of deoxycorticosterone to aldosterone in the mitochondria). Neonatal Task3 2/2 mice display a severe phenotype with a strong increase in plasma aldosterone, corticosterone, and progesterone that decreases with age (44) , with a significant increase in Cyp11b2 mRNA for the neonatal mice that normalizes in adults.
There is a marked increase in adrenal renin expression and concentration, mainly in the zF that decreases with age (44). ) resulted in a small, but significant increase in blood pressure with normal heart rate, a gender-independent decrease in plasma K + concentration, and an elevation of plasma aldosterone with normal renin or serum corticotropin levels (32) . The elevation of the blood pressure was a result of the hyperaldosteronism and the vascular dysfunction that resulted from the gene deletion.
Transgenic Mouse Models With Constitutively Activated b-Catenin
The Wnt/b-catenin signaling is essential for embryonic development and cell proliferation, but constitutive activation is associated with a variety of cancers (48) . In the absence of extracellular Wnt ligands, the N-terminal domain of b-catenin is phosphorylated on serines/ threonine residues by a multi-protein destruction complex composed of casein kinase I, glycogen synthase kinase 3b, axin, and adenomatous polyposis coli (APC), which results in ubiquitylation and proteosomal degradation. The binding to the Frizzled/lipoprotein receptorrelated protein receptor inhibits the destruction complex, and b-catenin is stabilized and undergoes nuclear translocation and activation of lymphoid enhancer factor/T cell factor transcription factors, resulting in increased gene expression (49) . b-Catenin plays a role in adrenal development (50), activated b-catenin has been shown to occur in adrenal cortical carcinomas and adenomas (48) , and activating mutations of b-catenin are found in some human aldosterone-producing adenomas (51) . Transgenic mice with an adrenal-restricted constitutive activation of b-catenin (DCat) display adrenal hyperplasia and dysplasia that produces profound changes in zonal identity and causes hyperaldosteronism in females, with some of the mice also developing adrenal cancers at 17 months of age (33) . Disease progression was slow in male DCat, mice and the study was largely performed in females; however, males also displayed adrenal hyperplasia but no signs of malignancy.
Transgenic Mouse Models With a Truncated Form of Adenomatous Polyposis Coli
As described previously, APC is a component of the destruction complex of b-catenin. Mice that express a defective mutant of Apc, which lacks the C-terminal portion of the gene (apc Min/+ ), develop multiple intestinal tumors (52) . These mice also exhibit hypertension with an increase in plasma volume, a marked increase in fractional urinary excretion of K + , a decrease in urinary Na + excretion, and an increase in plasma aldosterone and corticosterone concentrations (34) .
The aldosterone-responsive serum/glucocorticoidregulated kinase (SGK) 1 is also stimulated by bcatenin; therefore, stabilization of b-catenin would be expected to upregulate SGK1. Considerable evidence indicates that SGK causes an increase in the expression of cell-surface epithelial Na + channels, which function in the regulation of Na + and fluid reabsorption in the kidney and colon (53, 54) . Apc Min/+ /sgk 2/2 mice display increased aldosterone but not corticosterone levels compared with apc Min/+ mice, and the hypertension of apc Min/+ mice is ablated in the double-transgenic model (34) . This effect is attributed to the impaired Na + retention determined by the sgk deletion, whereas aldosterone secretion is directly affected by Apc-dependent signaling (34) . This suggests that the apc Min/+ mice are a model of PA, whereas the double apc Min/+ /sgk
transgenic model is a model of both primary and secondary aldosteronism. The normalization of hypertension by deletion of the sgk gene likely reflects the role of Sgk in epithelial Na + channels expression. The previous study on apc Min/+ and apc Min/+ /sgk 2/2 mice was performed using sex-matched mice of 3 months of age. No gender-related phenotype differences were reported. The potential relevance of APC variants in some patients with PA is indicated by a case report of a young patient with severe hypertension and PA in a background of familial adenomatous polyposis with a germline heterozygous APC mutation (55) . The patient displayed bilateral macronodular adrenal hyperplasia with lateralized aldosterone secretion. Molecular analysis and histopathology of the resected adrenal showed three nodules with one expressing CYP11B2 and carrying a somatic KCNJ5 mutation. This nodule and an additional nodule had a somatic biallelic APC inactivation that potentially triggered cell proliferation, with the KCNJ5 mutation providing the second genetic hit to drive the CYP11B2 overexpression (55) .
Mouse Models With Deletion of Cryptochrome-1 and Cryptochrome-2
Behavior, metabolism, and physiology are subject to a well-controlled, daily rhythm, regulated by a molecular oscillator called the circadian clock. Alteration of the circadian rhythm in shift workers, flight crews, and individuals with sleep disorders has a higher than average incidence of cardiovascular disorders (56) . Disruption of the circadian clock in cryptochrome (Cry) null mice that lack the core clock components Cry1 2/2 /Cry2 2/2 results in hyperaldosteronism with salt-sensitive hypertension and renal damage (57, 58) . Age-and gender-related variations were eliminated by the inclusion of only male mice, aged 12 to 16 weeks. The hyperaldosteronism is reportedly a result of dysregulation of the 3b-hydroxysteroid dehydrogenase b6 (Hsd3b6), which is overexpressed in the zG of the mouse adrenal. The expression of the aldosterone synthase is unchanged, and it is believed that overexpression of the Hsd3b6 allows further substrate to become available for the synthesis of aldosterone (35, 57) . The Hsd3b6 homolog in humans is the HSD3B1 isozyme, which is expressed in the zG of the human adrenal (58) . Period 1 (Per1) is another core component of the circadian clock, and Per1 and Cry2 can mediate opposing effects on target genes (59) . Mice with reduced Per1 levels in vivo display decreased plasma aldosterone concentrations and a reduction in Hsd3b6 expression (60) . This may be accounted for by an increase in Cry2 expression as Per1 levels decrease, which causes a dysregulation of Hsd3b6 gene expression.
Mouse Models With Differential Levels of Transforming Growth Factor b1 expression
Polymorphisms of the transforming growth factor b1 (TGFB1) gene located in the sequence coding the signal peptide are associated with a reduced risk of hypertension in a European population (61) , and a different polymorphism that affects a different amino acid in the signal peptide has been associated with hypertension in an Asian population (62) . The 3 0 untranslated region of the Tgfb1 gene was manipulated to increase or decrease the stability of the encoded mRNA. Male mice were then created to express Tgfb1 in five grades, from 10% to 300% that of normal. Plasma aldosterone and corticosterone concentrations increased as Tgfb1 gene expression levels decreased. Mice with the lowest Tgfb1 expression (Tgfb1 L/L ) had ;200% higher plasma aldosterone and corticosterone concentrations compared with wild-type, whereas the plasma aldosterone concentration of mice with the highest expression of Tgfb1 (Tgfb1 H/H ) was approximately halved. Expression of Cyp11b2 and Cyp11b1 followed the changes in Tgfb1 expression as predicted. The animals with decreased Tgfb1 had higher plasma volumes and elevated blood pressure and lower levels of Ang II (36) , and the hypertension was corrected with spironolactone.
Mouse Models Produced Using a Random Mutagenesis Screen
In attempt to find novel genetic loci associated with PA, a large-scale mutation screen was performed in mice injected with N-ethyl-N-nitrosourea (an alkylating agent that causes ethylation of nucleic acids, resulting in point mutations) to introduce randomly mutations into the mouse genome (37) . As expected, the resulting mutagenesis caused a phenotypic spectrum from total loss of function of some genes to gain of function and generated mouse lines with elevated plasma aldosterone concentrations in males but not in females. Exome nextgeneration sequencing identified eight mutated genes that were common between the F1 and F5 generations of the mice with high plasma aldosterone concentrations. Although animals carry more than one mutated gene, an attempt was made to correlate the expression of mutated genes with aldosterone levels, and animals carrying mutations in the Sspo, Dguok, Hoxaas2, and Clstn3 genes displayed higher aldosterone levels (63). Histological examination of the adrenal did not reveal any adenomas or hyperplasia but exhibited an increased staining for the Cyp11b2 enzyme that was more pronounced in the middle and inner areas of the adrenal cortex compared with wild-type animals, suggesting an altered zonation of Cyp11b2. Further studies will be necessary to characterize each individual gene in the regulation of aldosterone.
Mouse Models With an Increased Expression of the Aldosterone Synthase Gene
The biosynthesis of aldosterone depends on the transcriptionally regulated last enzyme in the pathway, aldosterone synthase (CYP11B2) (19) . Male and female mice were generated with increased stability of the Cyp11b2 mRNA by substitution of the 3 0 untranslated region with the more stable 3 0 untranslated sequence of the bovine growth hormone mRNA (38) . Cyp11b2 hi/hi mice displayed a slight increase in Cyp11b2 mRNA expression on a normal sodium diet with normal plasma aldosterone concentrations that were higher than those of wild-type animals on a high sodium diet (38) . The Cyp11b2 hi/hi mice on a modest high-salt diet infused with Ang II had a higher blood pressure, cardiac hypertrophy, and oxidative stress than wild-type animals (38) . There were no reported phenotype differences related to gender. The modest elevation of aldosterone synthase expression in humans could result in the development of hypertension in societies that consume a high sodium diet.
Transgenic mice were produced with the promoter region of the human CYP11B1 gene fused to the coding region of the human CYP11B2 gene (39) . The heterozygous mice, called hAS +/2 , were shown to be hyperaldosteronemic and hypertensive when administered a high salt diet, and as expected, the plasma K + was lower and Na + higher than the wild-type mice. The high salt-induced hypertension was normalized by the administration of fadrozole, an aldosterone synthase inhibitor. These mice could be useful for the study of the cardiovascular and renal effects of endogenous-elevated aldosterone.
Perspectives and Conclusions
Mouse models of human disease often fail to represent the whole clinical spectrum. Although several mouse models of hyperaldosteronism have been described over recent years, they have not reproduced a genetic alteration shown to cause PA in humans and do not display the tumor formation or hyperplasia that reflect the pathophysiology of this disease. These models are, however, valuable to study mechanisms of fluid and electrolyte homeostasis and the regulation of aldosterone production, as well as providing potential targets for the pharmacological treatment of conditions where aldosterone production is elevated, as in PA.
Humans and rodents display some notable differences in adrenal physiology with alternative patterns of adrenal steroid production and distinct differences in the expression of K + channels that maintain the membrane potential of zG cells. This divergence underscores the dubious suitability of available mouse models to resemble human pathophysiology. Further refined mouse models with inducible, zone-specific introduction of point mutations that have been observed in human disease could represent one possible approach to fill this gap. Furthermore, the adrenal physiology of larger animals, such as pigs, that are useful to model complex disease traits, could also resemble more closely that of humans and may offer the possibility to recapitulate genetic hits in ion pumps and channels that have been shown to cause the human disorder. Yet, pigs express a single CYP11B enzyme for aldosterone and cortisol synthesis instead of the two enzymes expressed in humans (CYP11B2 and CYP11B1). Notwithstanding this complexity, the sequencing of the pig genome by the Swine Genome Sequencing Project and advances in genome-editing technologies render feasible the production of a pig knockin model of PA with an adrenal-expressing human CYP11B1 and CYP11B2 to provide data that can be translated to the human condition.
